Nevertheless, monitoring for symptomatic hypoglycaemia remained an integral part of the protocol at every dosage level, especially for participants also using background glucose-lowering therapies
Retatrutide is currently being studied for several metabolic conditions, including: Cardiovascular disease Chronic lower back pain Knee osteoarthritis Obesity and chronic weight management Obstructive sleep apnea Type 2 diabetes Like other incretin-based drugs, retatrutide is given as a weekly injection during clinical trials
In recent years, the interest in kidney hypoxia as a driver of DKD has been revived owing to the development of techniques that allow the study of kidney oxygen availability
I read through the Federal Register comments written by pharma companies for a longer (paid) piece I did on pharma tariffs.3 Many of the companies asked the Trump administration to continue to exclude pharma products from any tariffs
All Body Types: Regardless of your body type, it is suitable for everyone, including moderate situations
Last week, the ABC revealed that doctors were warning people not to take drugs labelled as "retatrutide" after seeing multiple cases of life-threatening illness, including acute liver failure